Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mariantonietta Di Salvatore
Observed names:
M Di Salvatore,
M. Di Salvatore,
Mariantonietta di Salvatore
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0002-3796-3877
Observed ORCID:
0000-0002-3796-3877
OpenAlex ID:
A5066923986
Is There a Role for IGF1R and c-MET Pathways in Resistance to Cetuximab in Metastatic Colorectal Cancer?
2011
·
Alessandro Inno
, Mariantonietta Di Salvatore
, et al.
·
Clinical Colorectal Cancer
·
88
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer
2021
·
Ina Valeria Zurlo
, Mattia Schino
, et al.
·
Cancer Immunology Immunotherapy
·
83
PDF
Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line
2011
·
M. Di Salvatore
, A. Orlandi
, et al.
·
Cell Proliferation
·
70
PDF
Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells
2007
·
A. Sgambato
, B. De Paola
, et al.
·
Journal of Cellular Physiology
·
51
PDF
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer
2021
·
Donatella Lucchetti
, Ina Valeria Zurlo
, et al.
·
Scientific Reports
·
45
PDF
Multimodality treatment in recurrent/metastatic squamous cell carcinoma of head and neck: current therapy, challenges, and future perspectives
2024
·
Sergio Pannunzio
, Armando Di Bello
, et al.
·
Frontiers in Oncology
·
34
PDF
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients
2017
·
Mariantonietta Di Salvatore
, Filippo Pietrantonio
, et al.
·
Oncotarget
·
34
PDF
Body Composition Changes in Gastric Cancer Patients during Preoperative FLOT Therapy: Preliminary Results of an Italian Cohort Study
2021
·
Emanuele Rinninella
, Antonia Strippoli
, et al.
·
Nutrients
·
33
PDF
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients
2012
·
M Basso
, A Strippoli
, et al.
·
British Journal of Cancer
·
29
PDF
Let-7a-5p, miR-100-5p, miR-101-3p, and miR-199a-3p Hyperexpression as Potential Predictive Biomarkers in Early Breast Cancer Patients
2021
·
Paola Fuso
, Mariantonietta Di Salvatore
, et al.
·
Journal of Personalized Medicine
·
28
PDF
Treatment of Locally Advanced Gastric Cancer (LAGC): Back to Lauren’s Classification in Pan–Cancer Analysis Era?
2020
·
Ina Valeria Zurlo
, Michele Basso
, et al.
·
Cancers
·
25
PDF
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas
2014
·
A. Orlandi
, M. Di Salvatore
, et al.
·
Journal of Cancer
·
23
PDF
Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer
2022
·
Alessio Stefani
, Geny Piro
, et al.
·
Frontiers in Oncology
·
18
PDF
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis
2015
·
M. Di Salvatore
, L. Lo Giudice
, et al.
·
Clinical & Translational Oncology
·
17
Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis
2025
·
Federico Monaca
, Igor Gomez-Randulfe
, et al.
·
European Journal of Cancer
·
13
PDF
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program
2024
·
Antonio Vitale
, Luca Mastrantoni
, et al.
·
JCO Precision Oncology
·
13
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC)
2023
·
Emanuele Vita
, Alessio Stefani
, et al.
·
Cancer Immunology Immunotherapy
·
13
PDF
Low frequency of hCDC4 mutations in human primary ovarian cancer
2007
·
A. Sgambato
, V. Masciullo
, et al.
·
Gynecologic Oncology
·
11
Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma
2021
·
Emanuele Vita
, Alessio Stefani
, et al.
·
Journal of Clinical Medicine
·
10
PDF
ERCC1, KRAS mutation, and oxaliplatin sensitivity in colorectal cancer: Old dogs and new tricks.
2012
·
Armando Orlandi
, Mariantonietta Di Salvatore
, et al.
·
Journal of Clinical Oncology
·
10
Lung adenocarcinoma presenting as a solitary gingival metastasis: a case report
2011
·
Armando Orlandi
, Michele Basso
, et al.
·
Journal of Medical Case Reports
·
10
PDF
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK‐positive advanced non–small cell lung cancer
2024
·
Emanuele Vita
, Federico Monaca
, et al.
·
Cancer
·
8
PDF
Multifocal hepatic small vessel neoplasm with spleen dissemination
2022
·
Carlo Maria Cicala
, Federico Monaca
, et al.
·
BMJ Case Reports
·
8
Erlotinib for Patients with EGFR Wild-Type Metastatic NSCLC: a Retrospective Biomarkers Analysis
2018
·
Alessandro Inno
, Vincenzo Di Noia
, et al.
·
Pathology & Oncology Research
·
6
The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures
2021
·
Miriam Grazia Ferrara
, Alessio Stefani
, et al.
·
Frontiers in Oncology
·
5
PDF
Show more works
View as search
Works count:
69
Citation count:
725
H-index:
14
I10-index:
21
Year
Topic
Type